Community Perspectives on Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndrome

2 Views
administrator
administrator
07/04/23

Join experts on treating higher-risk myelodysplastic syndromes and acute myeloid leukemia.

Supported by independent educational grants from AbbVie; Actinium Pharmaceuticals; Biomea Fusion; Gilead Sciences, Inc.; GlycoMimetics, Inc.; and Rigel Pharmaceuticals, Inc.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next